Management ChangeJun 24, 2026, 07:56 AM
Picard Medical CEO Schnegelsberg Steps Down; Fang Appointed Interim
AI Summary
Picard Medical, Inc. announced a leadership transition with Patrick NJ Schnegelsberg stepping down as Chief Executive Officer and Board member, effective June 18, 2026. His departure was stated not to be due to any disagreement. The Board appointed Richard Fang, Ph.D., the current Chairman, as Interim Chief Executive Officer, effective the same date. Dr. Fang, who previously served as CEO from September 2021 to July 2023, will continue in his role as Chairman and will receive an annual salary of $400,000 as Interim CEO.
Key Highlights
- Patrick NJ Schnegelsberg stepped down as CEO and Board member, effective June 18, 2026.
- His departure was not due to any disagreement with the Company.
- Richard Fang, Ph.D., was appointed Interim Chief Executive Officer, effective June 18, 2026.
- Dr. Fang will continue to serve as Chairman of the Board.
- Dr. Fang previously served as CEO from September 2021 until July 2023.
- Dr. Fang will receive an annual salary of $400,000 as Interim CEO.
- Dr. Fang is a founder of Hunniwell Lake Ventures LLC and Reach Surgical.
Price Impact
More from PMI